Saffron, St. John's Wort, Rhodiola for Low Mood: The Evidence

Where These Herbs Fit Saffron St. John's Wort Extract or Whole Herb Interactions Rhodiola Ginkgo Side by Side Vitamins and Supplements Buying Well Who Should Avoid FAQ

Updated September 2, 2026

Four herbs come up in nearly every conversation I have about low mood: saffron, St. John's wort, rhodiola rosea, and ginkgo biloba. People talk about them as though they are interchangeable options on the same shelf. The research behind each one is different, and so is what you need to know before taking any of them.

The herbs and supplements with the most trial data on mood are saffron and St. John's wort, tested in small studies of people diagnosed with mild to moderate depression. Rhodiola has one positive placebo-controlled trial and one that found no difference. Ginkgo has mostly been tested as an add-on. None of them replaces care for persistent or severe symptoms.

Key takeaways

• Small trials comparing saffron with antidepressants did not detect a difference in symptom scores, which is not the same as showing the herb performs as well. Heat destroys its active compounds, so preparation matters.
• St. John's wort has the largest body of research and fewer side effects than prescription antidepressants, but the standard extract is built around a marker compound that is probably not doing the work, and its drug interactions rule it out for many people.
• Rhodiola suits low mood that arrives with exhaustion. Check thyroid function when that is the picture.
• Ginkgo is an adjunct where mental fog or circulation is part of the picture, not a primary herb.
• Daylight, sleep, movement, and nutrient status shape mood more reliably than any capsule.

Every one of us is worth keeping here, including you on the days that feel otherwise. If you are struggling, please reach out to someone. In the United States, call or text 988 for the Suicide and Crisis Lifeline, any hour.

Nothing here is medical advice. It is educational information and is not intended to diagnose, treat, cure, or prevent any condition. Do not stop or change a prescribed medication without your prescriber.

Where These Herbs Fit, and Where They Do Not

Evidence: clinical context, not a trial finding.

Low mood covers a lot of ground. At one end is a flat stretch that lifts in a few weeks. At the other is an illness that takes sleep, appetite, and the will to keep going. The trials covered below enrolled people diagnosed with mild to moderate depression, under clinical supervision, for six to twelve weeks. That is the context the data comes from. It says nothing about severe depression, bipolar depression, or anything involving thoughts of self-harm, and those situations need a clinician, not a tincture.

Saffron

Evidence: multiple small randomized trials, most from one country, with six to twelve week follow-up. Reviewed in full in the linked article.

Saffron is the dried stigma of the crocus flower, harvested by hand, and the most expensive spice in the world by weight. Persian and Ayurvedic medicine used it for low mood for centuries before any trial existed.

Since 2004, randomized trials of 30 to 80 adults have tested 30 mg per day of stigma extract against placebo, imipramine, and fluoxetine over six to twelve weeks. Against placebo, saffron lowered depression scores with a large pooled effect. Against the drugs, the trials found no statistically significant difference, but with 15 to 20 people per group they could only have detected a large gap, and the pooled comparison leaned slightly toward the drugs. Nearly every trial came from Iran, and one research group produced most of the early data. I go through each trial, the doses used, and the limits of the evidence in Saffron and Mood: What the Clinical Trials Measured.

Preparation, which matters more than the dose

Saffron's active compounds are fragile. Crocin degrades with heat and light, and safranal is volatile and evaporates. A 2024 study simulating cooking conditions between 60 and 100°C confirmed that crocins lose function when exposed to heat, oxygen, light, and acidity. Saffron rice, although tasty, is unlikely to carry any of the effect measured in trials, and the trials themselves used standardized capsules rather than culinary threads.

The traditional preparation is saffron steeped in warm milk, warm rather than boiling. Milk carries fat, and saffron's crocetin and safranal fractions are fat soluble, so the fat helps carry them, while the water in milk handles the water-soluble crocin, making it a well-chosen vehicle arrived at long before anyone could measure why.

Sourcing and safety

Because it is so expensive, saffron is one of the most adulterated botanicals on the market. Safflower, turmeric, dyed corn silk, and shredded beet fiber all turn up in what is sold as saffron. If the price looks reasonable, that is information. Buy from a supplier who tests and can name the growing region.

Saffron has no well-documented major drug interactions at culinary or supplemental doses. Some studies report mild antiplatelet activity, so mention it to your prescriber if you take an anticoagulant. Classical texts treat it as a uterine stimulant, so avoid it in pregnancy at anything above culinary amounts.

St. John's Wort

Evidence: 2008 Cochrane review of 29 trials, later systematic review of 35 trials, one null US trial. Mechanism not established.

No herb studied for mood has been studied more. That volume of research is also where much of the confusion comes from, because most of it was designed around an assumption that has not held up.

What the trials found

The 2008 Cochrane review pooled 29 randomized double-blind trials covering 5,489 patients. Hypericum extracts beat placebo, matched standard antidepressants on symptom scores, and caused fewer side effects than those antidepressants. A later systematic review of 35 trials and 6,993 patients reached the same conclusion on tolerability. That is a finding about side effects, which is separate from the drug interactions covered further down.

Two things complicate the efficacy picture. Trials from German-speaking countries, where the herb has a long clinical tradition, showed clearly stronger results than trials run elsewhere. And the best-known American trial, published in JAMA in 2002, found no benefit over placebo in moderately severe major depression. Sertraline was included as an active comparator in that trial and also failed to separate from placebo.

What we do not know about how it works

Nobody has established how St. John's wort works. The explanation you will read everywhere, that it affects serotonin reuptake the way an SSRI does, was not a finding. The herb appeared to help, SSRIs were understood to help by acting on serotonin, so the herb was presumed to act on serotonin too. Mechanistic work then went looking for that effect using isolated constituents in cell models, which is a long way from a person taking a tincture.

The assumption underneath it has since taken a serious hit. A 2022 umbrella review in Molecular Psychiatry pulled together the main bodies of evidence on serotonin and depression, covering serotonin and metabolite concentrations, receptor binding, transporter levels, tryptophan depletion, and gene studies, and found no consistent evidence that depression involves lowered serotonin concentration or activity. The review drew substantial pushback and the argument is still live. Either way, a product designed around an assumed mechanism may be designed around the wrong thing.

Standardized Extract or Whole Herb

Evidence: pharmacognosy and clinical observation. The active constituent has not been identified.

Nearly every St. John's wort product on the shelf is standardized to 0.3 percent hypericin, at 300 mg three times daily. That became the consensus preparation, and it is what most trials used.

Hypericin is a red pigment characteristic of the Hypericum genus. It is easy to measure, it makes a tidy marker, and it is probably not the compound responsible for the effect on mood. It became the standardization target because it was convenient.

Hyperforin is the better candidate, and it also drives the drug interactions. Its content varies enormously between products, and most labels do not mention it. Two bottles both reading 0.3 percent hypericin can behave completely differently in the body. This is a reasonable explanation for something I hear often, which is that someone took St. John's wort for two months and felt nothing.

Traditionally the whole herb was used: the flowering tops in tincture, in infusion, or as the deep red infused oil. The whole plant contains hypericin, hyperforin, flavonoids, and a long list of compounds nobody has assigned a role to yet. When there are no contraindications in the way, whole herb preparations are what I reach for, because we do not know enough about which fraction does the work to justify throwing most of the plant away.

Whole herb does not mean interaction-free. A full-spectrum preparation carries the full hyperforin load, and everything in the next section applies to whole herb at least as much as to extracts.

The Interaction Problem

Evidence: published case reports, pharmacokinetic studies, and a 2020 clinical review. This is the best-documented part of the St. John's wort literature.

St. John's wort activates a receptor in the liver and gut called the pregnane-X receptor. That switches on cytochrome P450 enzymes, chiefly CYP3A4, and a transport protein called P-glycoprotein. Many medications then get cleared faster than intended, blood levels drop, and the drug stops working.

The documented list includes cyclosporine, tacrolimus, digoxin, warfarin, indinavir, alprazolam, simvastatin, methadone, and oral contraceptives.

What this has caused in practice

• Transplant rejection. A published case describes a kidney and pancreas recipient whose cyclosporine levels fell below therapeutic range after she started St. John's wort. She lost the graft and went back on dialysis. Two heart transplant patients had comparable rejection episodes.
• Contraceptive failure. Reported cases include breakthrough bleeding and unplanned pregnancy.
• Loss of anticoagulant control. Warfarin levels drop, raising clotting risk in people taking it to prevent exactly that.

Hyperforin drives this in proportion to dose, which is why the preparation changes the risk. A phase I study in 20 healthy volunteers tested a deliberately low-hyperforin extract and found no pharmacokinetic interactions with CYP1A2, CYP2B6, CYP2C9, CYP2C19, CYP3A4, or P-glycoprotein. That finding sits awkwardly next to the whole herb argument, since hyperforin may well be part of what makes the plant work.

The enzyme induction takes one to two weeks to build fully and lingers one to two weeks after the last dose, so the risk window outlasts the bottle. Separately, combining St. John's wort with an SSRI, SNRI, triptan, or tramadol raises the risk of serotonin syndrome. That is a different mechanism and it applies to any preparation.

Tell every prescriber and pharmacist you see, and mention it before surgery.

Rhodiola Rosea

Evidence: one positive placebo-controlled trial (2007) and one 12-week trial (2015) that found no significant difference from placebo or sertraline.

Rhodiola is an arctic and alpine root with a long history in Scandinavian and Russian medicine. It is one of a small handful of herbs that meets the classical definition of an adaptogen, meaning it raises what is low and settles what is high according to what the body needs rather than pushing in one fixed direction. Its studied constituents are salidroside and the rosavins.

The trial most often cited is Darbinyan and colleagues, 2007, six weeks, randomized, double-blind, placebo-controlled, in people diagnosed with mild to moderate depression. Both dose groups improved on the Hamilton and Beck scales against placebo.

The harder test came later. Mao and colleagues, 2015, randomized 57 people to rhodiola, sertraline, or placebo for 12 weeks at the University of Pennsylvania. All three groups improved modestly and none of the differences reached significance. Rhodiola caused fewer adverse effects than sertraline, and the authors suggested a more favorable balance of benefit to risk, but the trial did not show that it works.

Low mood with fatigue and stress

Where I reach for rhodiola is the picture that mixes low mood with exhaustion, poor stress tolerance, and mental fog. That combination is also a flag. When I see it I want thyroid function checked, because low thyroid produces exactly this presentation, it is common in a culture that treats constant output as normal, and it will not respond to an adaptogen when the adaptogen is not the missing piece. Rhodiola can support someone through the investigation. It should not replace it.

Rhodiola in the morning or at night

Morning. Rhodiola is stimulating for some people, and late dosing costs sleep. Lost sleep costs mood, so an evening dose can undo the reason for taking it.

Ginkgo Biloba

Evidence: 2024 systematic review of 21 mostly adjunctive trials with very high heterogeneity. Primary literature concerns cognition and circulation.

Most of the scientific literature on ginkgo is not about mood at all. It is about dementia, cognition, and circulation. That explains why the mood evidence looks the way it does.

The largest analysis is a 2024 systematic review of 21 trials covering 2,074 patients, reporting lower Hamilton scores at four, six, and eight weeks. Most of those trials gave ginkgo alongside a conventional antidepressant and compared that against the antidepressant alone. Most participants had post-stroke depression, vascular depression, or depression alongside another illness. Heterogeneity ran between 91 and 95 percent on the main outcomes, meaning the trials disagreed with each other substantially, and the authors found no qualifying trials in the United States or Europe.

None of that makes ginkgo useless. It means the trials were not designed to answer the question most people are asking. Poor concentration, mental fog, and slowed thinking are core features of low mood, and ginkgo's studied actions on cerebral circulation and cognition are relevant to those features. Many herbalists, including me, use it as a supporting herb on that reasoning. It earns its place most clearly in older adults, after stroke, or where circulation is already a concern.

Ginkgo has antiplatelet activity, so it raises bleeding risk alongside anticoagulants and before surgery.

The Four Side by Side

Evidence: summary of the sections above.

Herb	Evidence	Suits	Main caution
Saffron	Beat placebo in small trials. Comparisons with antidepressants detected no difference but were too small to show equivalence. Nearly all trials from one country.	Low mood, and low mood with anxiety.	Heat destroys it. Heavily adulterated. Avoid in pregnancy.
St. John's wort	Largest body of research. Beats placebo and matches antidepressants in mild to moderate cases, with fewer side effects.	Low mood in someone taking no other medication.	Serious drug interactions. Standard extract may be built around the wrong compound.
Rhodiola	One positive placebo-controlled trial. A better-designed trial found no significant difference from placebo or sertraline.	Low mood with fatigue, burnout, poor stress tolerance. Check thyroid alongside it.	Stimulating. Take in the morning.
Ginkgo	Research focuses on cognition and circulation. Mood trials are mostly adjunctive.	An adjunct where mental fog, poor concentration, or circulation are part of the picture.	Raises bleeding risk. Stop before surgery.

Handmade in Montana

← →

Vitamins and Supplements for Mood

Evidence: mixed. Exercise and sleep have trial support. Nutrient associations are observational unless noted.

An herb cannot outrun conditions that keep producing the symptom. The supplements that improve mood most reliably are the ones correcting a deficiency you have, which is why testing comes before buying. These are worth looking at whether or not you ever open a bottle of anything.

Daylight and vitamin D

Light hitting the eye in the morning sets circadian timing, which governs sleep, cortisol rhythm, and mood. Light hitting skin makes vitamin D, and low vitamin D is one of the most common deficiencies in anyone living at a northern latitude or working indoors. Spend 20 minutes outdoors within an hour of waking, without sunglasses. In winter, or if you are inside most of the day, get 25-OH vitamin D tested rather than guessing. It is fat soluble, so supplementing blind is not the harmless move people assume.

Sleep

Disrupted sleep both follows low mood and feeds it, and it is often the first thing worth fixing. A consistent wake time does more than a consistent bedtime. Dark room, cool room, no screens for the last hour. If you snore heavily or wake unrefreshed no matter how long you were down, ask about sleep apnea. It produces a fatigue and low mood picture that no herb will touch.

Movement

Exercise has trial evidence for depressive symptoms that compares well against medication. Frequency beats intensity. Walking counts, and walking outdoors in the morning covers daylight at the same time.

Micronutrients worth testing

Any of these can produce fatigue, low mood, and poor concentration on their own, and all of them get missed.

What to check	Why	Ask for
Vitamin D	Widespread deficiency, associated with low mood, driven by indoor living.	25-OH vitamin D
Iron	Low iron causes fatigue and low mood well before anemia shows up.	Ferritin, not just hemoglobin
B12 and folate	Both required for neurotransmitter synthesis. Deficiency mimics low mood closely.	Serum B12, folate, homocysteine
Thyroid	Hypothyroidism brings fatigue, low mood, and cognitive fog, and gets missed constantly.	Full panel, not TSH alone
Magnesium	Involved in stress response and sleep. Short supply in most modern diets.	Usually assessed by intake rather than blood level
Omega-3 fats	Structural components of neuronal membranes. Intake is low in most Western diets.	Omega-3 index where available

Blood sugar swings drive irritability, fatigue, and afternoon crashes that read as mood symptoms, and protein and fat at breakfast instead of carbohydrate alone often settles them. Alcohol is a depressant that also fragments sleep, so the effect compounds. Two weeks off it tells you more than any argument about it.

Buying Well

Evidence: sourcing practice and adulteration reports.

• Saffron: sourcing is the whole game. Buy from someone who tests and can name the growing region. A low price is a warning.
• St. John's wort: if you are choosing an extract, look for declared hyperforin content, because hypericin alone tells you very little. If you are choosing whole herb, look for flowering tops harvested in season with a visible red color in the tincture or oil.
• Rhodiola: check the Latin binomial. Rhodiola rosea root is not the same as other Rhodiola species sold under the same common name.
• All of them: ask for a certificate of analysis for the specific lot. A supplier who will not send one has told you something.
• Ignore "therapeutic grade." No regulator issues it and no standard defines it.
• Read combination formulas all the way through. Mood blends often include St. John's wort in a supporting role without making it obvious, and that is enough to cause an interaction.

Who Should Avoid These

Evidence: documented interactions and safety data gaps.

• Anyone on a prescription antidepressant should not add St. John's wort, because of serotonin syndrome risk.
• Anyone on an immunosuppressant, anticoagulant, antiretroviral, chemotherapy drug, or hormonal contraceptive should avoid St. John's wort. Treat any product that will not disclose hyperforin content as high hyperforin.
• Bipolar disorder: approach all four carefully. Antidepressant activity of any kind can trigger mania, and St. John's wort has been associated with induced mania.
• Pregnancy and breastfeeding: skip saffron beyond culinary amounts, and understand that safety data are insufficient for all four.
• Before surgery: stop St. John's wort and ginkgo at least two weeks ahead, for anesthetic interactions and bleeding risk.
• Sun exposure: St. John's wort can increase photosensitivity, more so at higher doses and in fair skin.

Frequently Asked Questions

Evidence: drawn from the sections above.

Which herbs and supplements improve mood?

Among herbs, St. John's wort has the most research by volume and saffron has the most direct comparisons against antidepressants. Among supplements, the ones that help most reliably are those correcting a deficiency you have, which usually means vitamin D, iron, B12, or folate. Test before buying.

Is saffron as effective as antidepressants?

The trials that compared them did not detect a difference, but they enrolled 30 to 40 people and ran six weeks, which is too small to show equivalence. The pooled comparison leaned slightly toward the drugs. The full trial record is in the saffron review.

Why is saffron prepared with warm milk?

Its compounds are heat sensitive and partly fat soluble. Warm milk keeps the temperature low enough to preserve them and supplies fat to carry the fat-soluble fractions, while the water carries the rest. Warm to the touch rather than simmering.

Does St. John's wort have fewer side effects than antidepressants?

Yes. The 2008 Cochrane review and a later systematic review of 35 trials both found fewer adverse events on St. John's wort than on antidepressant medication. Its drug interactions are a separate matter, and they are where the caution belongs.

Why does standardized St. John's wort sometimes do nothing?

The standard product is 300 mg of extract standardized to 0.3 percent hypericin, three times daily. Hypericin was chosen as the marker because it is easy to measure, and it is probably not the active constituent. Hyperforin is the better candidate, and it varies enormously between products without appearing on most labels. A product can be accurate on its label and still deliver nothing useful.

Is whole herb better than a standardized extract?

When there are no contraindications in the way, that is what I use. The whole plant contains hypericin, hyperforin, flavonoids, and compounds nobody has assigned a role to yet, and we do not understand the mechanism well enough to justify discarding most of it. Whole herb does not lower the interaction risk. It delivers the full hyperforin load.

How does St. John's wort work?

Nobody knows. The serotonin reuptake explanation was an assumption borrowed from how SSRIs were understood to work, and the mechanistic research behind it used isolated compounds in cell models. A 2022 umbrella review in Molecular Psychiatry found no consistent evidence linking depression to lowered serotonin. That review is still being argued over.

Can I take St. John's wort with an SSRI?

No. Combining it with an SSRI, SNRI, or other serotonergic drug raises the risk of serotonin syndrome, and it can speed clearance of the medication itself. Do not add it to a prescription, and do not stop a prescription to start it without your prescriber.

What are the most dangerous St. John's wort interactions?

Immunosuppressants such as cyclosporine and tacrolimus, where transplant rejection has happened. Anticoagulants such as warfarin. Antiretrovirals. Hormonal contraceptives, where unplanned pregnancies have been reported. Also digoxin, simvastatin, alprazolam, methadone, and some chemotherapy drugs. The effect builds over one to two weeks and lingers one to two weeks after stopping.

Is rhodiola better than an antidepressant?

The one trial that tested this directly did not show that. Rhodiola, sertraline, and placebo all produced modest improvement over 12 weeks with no significant difference between them. Rhodiola caused fewer side effects, which speaks to tolerability rather than efficacy.

Should rhodiola be taken in the morning or at night?

Morning. It is stimulating for some people and can disrupt sleep when taken late in the day.

What is an adaptogen?

An adaptogen raises what is low and settles what is high according to what the body needs. Very few herbs meet that definition properly, and rhodiola is one of them. The word gets applied loosely on supplement labels to almost anything, which has drained most of its meaning.

Could my low mood and fatigue be thyroid?

It is worth ruling out. Hypothyroidism produces low mood, exhaustion, cognitive fog, cold intolerance, and weight change, and the overlap is close enough that it gets missed regularly. Ask for a full thyroid panel rather than TSH alone.

Does ginkgo biloba help low mood?

The research on ginkgo focuses on dementia, cognition, and circulation, and the mood trials that exist mostly added it to a conventional antidepressant in older adults with post-stroke or vascular depression. Its actions still make sense as support where mental fog, poor concentration, or circulation are part of someone's picture. Treat it as an adjunct.

Can low vitamin D cause low mood?

Low vitamin D is associated with depressive symptoms, and it is one of the most common deficiencies in people who live somewhere northern or work indoors. Whether correcting it changes mood is less settled than the association. Test it either way, since deficiency produces fatigue and low mood on its own.

What should I check before assuming it is depression?

Thyroid, ferritin, B12 and folate, and vitamin D. All of them produce fatigue, low mood, and poor concentration, and all of them get missed. Ask for a full thyroid panel rather than TSH alone, and ferritin rather than hemoglobin alone.

How long before an herb would show an effect?

Most trials measured change at four to eight weeks. Give it that long, and write down how you are doing along the way.

Can herbs replace therapy or medication?

Not in moderate to severe depression, not in bipolar disorder, and not when there are thoughts of self-harm. The trial data comes from mild to moderate presentations under clinical supervision, and results are better when sleep, daylight, movement, and nutrient status are handled at the same time.

Choosing the herb is the last step. What you are already taking, what your labs show, how much daylight you get, and how you sleep all matter more. Book an educational consultation to talk through your own picture.

This article is for education only and is not medical advice. It does not replace diagnosis or treatment from a qualified practitioner. Do not start, stop, or change any medication based on what you read here. If you are in crisis or having thoughts of harming yourself, call or text 988 in the United States to reach the Suicide and Crisis Lifeline.

Sources

• Akhondzadeh S, et al. Comparison of Crocus sativus L. and imipramine in the treatment of mild to moderate depression: a pilot double-blind randomized trial. BMC Complementary and Alternative Medicine. 2004;4:12.
• Tóth B, et al. The efficacy of saffron in the treatment of mild to moderate depression: a meta-analysis. Planta Medica. 2019;85(1):24-31.
• Cerdá-Bernad D, et al. Distribution of main bioactive compounds from saffron species as a function of infusion temperature and time in an oil/water system. Foods. 2024;13(13):2033.
• Linde K, Berner MM, Kriston L. St John's wort for major depression. Cochrane Database of Systematic Reviews. 2008;(4):CD000448.
• Hypericum Depression Trial Study Group. Effect of Hypericum perforatum (St John's wort) in major depressive disorder: a randomized controlled trial. JAMA. 2002;287(14):1807-1814.
• Apaydin EA, et al. A systematic review of St. John's wort for major depressive disorder. Systematic Reviews. 2016;5:148.
• Moncrieff J, et al. The serotonin theory of depression: a systematic umbrella review of the evidence. Molecular Psychiatry. 2022.
• Nicolussi S, et al. Clinical relevance of St. John's wort drug interactions revisited. British Journal of Pharmacology. 2020;177(6):1212-1226.
• Zahner C, et al. No clinically relevant interactions of St. John's wort extract Ze 117 low in hyperforin with cytochrome P450 enzymes and P-glycoprotein. Clinical Pharmacology and Therapeutics. 2019;106(2):432-440.
• Zhou S, et al. Pharmacokinetic interactions of drugs with St John's wort. Journal of Psychopharmacology. 2004;18(2):262-276.
• Barone GW, et al. Drug interaction between St. John's wort and cyclosporine. Annals of Pharmacotherapy. 2000;34(9):1013-1016.
• Darbinyan V, et al. Clinical trial of Rhodiola rosea L. extract SHR-5 in the treatment of mild to moderate depression. Nordic Journal of Psychiatry. 2007;61(5):343-348.
• Mao JJ, et al. Rhodiola rosea versus sertraline for major depressive disorder: a randomized placebo-controlled trial. Phytomedicine. 2015;22(3):394-399.
• Lin J, Sun X, Yang L. Effects and safety of Ginkgo biloba on depression: a systematic review and meta-analysis. Frontiers in Pharmacology. 2024;15:1364030.
• Brondino N, et al. A systematic review and meta-analysis of Ginkgo biloba in neuropsychiatric disorders. Evidence-Based Complementary and Alternative Medicine. 2013;2013:915691.